No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CAH240726C97000
- 0.79
- +0.19+31.67%
15min DelayTrading Jul 22 10:04 ET
0.79High0.66Low
0.66Open0.60Pre Close3 Volume86 Open Interest97.00Strike Price211.00Turnover27.08%IV1.48%PremiumJul 26, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.79Extrinsic Value100Contract SizeAmericanOptions Type0.4565Delta0.1350Gamma107.07Leverage Ratio-0.1402Theta0.0054Rho48.88Eff Leverage0.0430Vega
Intraday
- 5D
- Daily
News
Germany Syringe Market Forecasts Report 2024: A $489.4 Million Market by 2029 Featuring Major Players - BD, B. Braun Melsungen, Terumo, Teleflex, Nipro, ICU Medical, and Cardinal Health
Express News | Citigroup Maintains Neutral on Cardinal Health, Lowers Price Target to $107
Cardinal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 11.95% Citigroup $115 → $107 Maintains Neutral 07/09/2024 9.86% Evercore ISI Group $115 → $105
Cardinal Health (NYSE:CAH) Shareholders Have Earned a 20% CAGR Over the Last Five Years
Cardinal Health, Inc. (NYSE:CAH) shareholders might be concerned after seeing the share price drop 12% in the last quarter. But that doesn't change the fact that the returns over the last five
Citigroup Adjusts Price Target on Cardinal Health to $107 From $115, Neutral Rating Maintained
Cardinal Health (CAH) has an average hold rating and a price target range of $92 to $130, according to analysts polled by Capital IQ.
Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Cuts Target Price to $107
Citi analyst Daniel Grosslight maintains $Cardinal Health(CAH.US)$ with a hold rating, and adjusts the target price from $111 to $107.According to TipRanks data, the analyst has a success rate of 50.4
Comments
$Cardinal Health(CAH.US$ hold and push
Despite an earnings beat, shares fell following a cut in guidance for the struggling Medical Segment. The CEO remains optimistic, but the market reacted negatively, with shares tumbling 5.5%.
1
Evercore ISI analyst Elizabeth Anderson praised the deal, seeing it as an important step forward for Cardinal's specialty growth strategy and a solid extension of the Navista network.
Just ahead of the Thanksgiving holiday, 41 S&P 500
stocks hit 52-week highs during Wednesday's trading session.
Meanwhile, one component of the Dow Jones Industrial Average hit a 52-week low. Chevron traded at lows not seen since September, 2022.
Of those the S&P names, 26 hit all-time highs, including:
![]()
Chipotle Mexican Grill ( $Chipotle Mexican Grill(CMG.US$ ), trading at all-time high levels back to its IPO in Jan, 2006
![]()
CBOE Holdings ( $Cboe Global Markets(CBOE.US$ ), tradin...
stocks hit 52-week highs during Wednesday's trading session.
Meanwhile, one component of the Dow Jones Industrial Average hit a 52-week low. Chevron traded at lows not seen since September, 2022.
Of those the S&P names, 26 hit all-time highs, including:
1
Cardinal Health's share price uptick reflects enhanced business performance but future growth may need revenue expansion and improved shareholder returns. Recent total shareholder return improvement indicates future business progress.
Read more